Skip to main content

Mass Spectrometry Market | Key Market Players Analysis

The global mass spectrometry market is projected to reach USD 5.27 Billion by 2022 from USD 3.68 Billion in 2017, at a CAGR of 7.4%. The mass spectrometry market is emerging and fragmented in nature with various regional and national players.
Sciex under Danaher Corporation (US) dominated the mass spectrometry market in 2016. The company provides a wide range of mass spectrometry technologies, accessories, and software in the mass spectrometry market. These products find application in a range of industries including pharmaceuticals, environmental agencies, food & beverage, petroleum industry, and research laboratories. To maintain its leading position and increase its customer base in the mass spectrometry market, the company mainly focuses on expanding its market presence by enhancing its product development capabilities and product launches & enhancements. For instance, in 2017, the company launched the Topaz LC-MS/MS System and the software called BioPharmaView 1.5 Software, an addition to its existing portfolio. The company has a strong R&D and manufacturing infrastructure, with its presence in Europe, North and South America, Asia, Africa, the Middle East and the Rest of the World.
Agilent Technologies (US) held the second position in the mass spectrometry market in 2016. It is a leading player in all developed regions including the US, Europe, and Asia. The company offers a wide range of mass spectrometry products, and also provides technical support. The prime strength of the company is innovation, which has helped it to sustain its brand equity. For instance, in 2017, the company has launched Ultivo triple quadrupole LC/MS, InfinityLab Series LC/MSD single quadrupole LC/MS, 6495B Triple Quadrupole LC/MS System, 7250 GC/Q-TOF system, and AdvanceBio 6545XT LC/Q-TOF LC/MS. The company also focuses on other growth strategies such as expansions to strengthen its position in the market. For instance, in 2017, the company opened a new Customer and Technology Center in Waldbronn, Germany to extend the company’s services to unexplored regions.
Thermos Fisher Scientific (US) was another leading player of global mass spectrometry market in 2016. The company offers a range of mass spectrometry technologies such as gas chromatography mass spectrometry (GC-MS), liquid chromatography mass spectrometry (LC-MS), inductively coupled plasma mass spectrometry (ICP-MS), and glow discharge mass spectrometry (GD-MS). To maintain its leading position, the company focuses on business strategies such as collaborations and expansions. For instance, in 2016, the company collaborated with the National Institute for Bioprocessing Research and Training (NIBRT), Ireland by providing its Orbitrap mass spectrometers for characterization of complex biopharmaceuticals.
Some of the other players competing in this market are Waters Corporation (US), Shimadzu Corporation (Japan), Bruker (US), Perkinelmer (US), JEOL (Japan), Analytik Jena (Endress Hauser) (Germany), Hiden Analytical (UK), and LECO (US).
Labels:

Comments

Post a Comment

Popular posts from this blog

Top 10 Medical Device Technologies Which Booming in 2019

The global top 10 medical device technologies market is expected to reach USD 428.97 Billion by 2020, at a CAGR of 5.5% from 2015 to 2020. Growth in the global top 10 medical device technologies market is mainly driven by factors such as the rising prevalence of chronic diseases and related increase in disability-adjusted life years (DALYs), technological advancements in medical devices, and growing aging population. Moreover, increasing investments from government bodies and private players in healthcare sectors in emerging economies and increasing focus of key players on emerging countries are creating new growth opportunities for this market. However, uncertainty in reimbursement and excise tax on medical devices in the U.S. are restraining the growth of the market. The top 10 medical device technologies market studied in this report is mainly segmented by types and region. Based on type, the top 10 medical device technologies market is segmented into in vitro diagnostics (IV
Post a Comment
Read more

In Situ Hybridization Market Growth Analysis - Global Forecast To 2021

According to the new market research report  " In situ Hybridization Market  by Technique (FISH, CISH), Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic And Research Institutions) - Global Forecast to 2021" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities. In the coming years, the market is expected to witness the highest growth in the Asia-Pacific region. This can be attributed to the growing presence of international players in China and India, increasing cancer prevalence and diagnosis, and increased healthcare expenditure across the Asia-Pacific region are drivers for the in situ hybridization market in this region. North America is expected to account for the largest share of the global market. This can be attributed to growing clinical and research in cancer by biotechnology and pharmaceutical companies, g
2 comments
Read more

Home Healthcare Market - Global Forecast to 2022 | CAGR of 8.8%

According to the new market research report " Home Healthcare Market  by Product (BP & Heart Rate Monitor, Ovulation Kit, HIV Test, ECG, Nebulizer, Hearing Aids, Pedometer, Cane, Crutches, Wheelchair), Software, Services (Rehabilitation, Pregnancy, Palliative), & Telehealth - Global Forecast to 2022" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities. Don’t miss out on business opportunities in Home Healthcare Market . Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=696 The global home healthcare market is expected to reach USD 364.69 Billion by 2022 from USD 220.67 Billion in 2016, at a CAGR of 8.8%. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The objectives of this study are as follows: To define, describe, segment and forecast the
1 comment
Read more